February 1, 2019 Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients Read more »
January 19, 2019 Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing Read more »
November 1, 2018 Development of a next-generation sequencing-based microsatellite instability assay (MSI NGS) for solid tumor testing Read more »
May 29, 2018 PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumab Read more »
July 1, 2018 Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors Read more »
February 3, 2018 CTLA-4 overexpression does not confer response to Ipilimumab in melanoma Read more »
November 1, 2018 Cell proliferation defines an additional mechanism of immune escape in non-small cell lung cancer Read more »